Hypoxia Enhances Lysophosphatidic Acid Responsiveness in Ovarian Cancer Cells and Lysophosphatidic Acid Induces Ovarian Tumor Metastasis In vivo
Open Access
- 15 August 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (16) , 7983-7990
Abstract
Lysophosphatidic acid (LPA) is elevated in ascites of ovarian cancer patients and stimulates growth and other activities of ovarian cancer cells in vitro. Tissue hypoxia is a critical factor for tumor aggressiveness and metastasis in cancers. We tested whether the ascites of ovarian cancer is hypoxic and whether hypoxia influences the effects of LPA on ovarian cancer cells. We found that ovarian ascitic fluids were hypoxic in vivo. Enhanced cellular responsiveness to LPA, including migration and/or invasion of ovarian cancer cells, was observed under hypoxic conditions. This enhancement could be completely blocked by geldanamycin or a small interfering RNA targeting hypoxia-inducible factor 1α (HIF1α). LPA-induced cell migration required cytosolic phospholipase A2 (cPLA2) and LPA stimulates cPLA2 phosphorylation in a HIF1α-dependent manner under hypoxia conditions. Furthermore, we show for the first time that exogenous LPA enhances tumor metastasis in an orthotopic ovarian cancer model and HIFα expression in tumors. 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (an inhibitor of the heat shock protein 90) effectively blocked LPA-induced tumor metastasis in vivo. Together, our data indicate that hypoxic conditions are likely to be pathologically important for ovarian cancer development. HIF1α plays a critical role in enhancing and/or sensitizing the role of LPA on cell migration and invasion under hypoxic conditions, where cPLA2 is required for LPA-induced cell migration. (Cancer Res 2006; 66(16): 7983-90)Keywords
This publication has 39 references indexed in Scilit:
- Biology of LPA in health and diseaseSeminars in Cell & Developmental Biology, 2004
- Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer CellsJournal of Biological Chemistry, 2004
- Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)Oncogene, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Targeting HIF-1 for cancer therapyNature Reviews Cancer, 2003
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Lysophospholipids Increase Interleukin-8 Expression in Ovarian Cancer CellsGynecologic Oncology, 2001
- Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasisCancer Letters, 1995
- Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapyInternational Journal of Cancer, 1989